Connected Medical Device Software Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Connected Medical Device Software Market Trends and Insights

Expansion of Remote Physiologic and Therapeutic Monitoring

CMS finalized CPT codes 98975–98980 for remote therapeutic monitoring, anchoring software procurement cycles for connected device platforms and making reimbursement-driven demand a structural market feature. The FDA’s December 2025 TEMPO Digital Health Devices Pilot granted enforcement discretion on premarket requirements while generating real-world evidence. Dexcom entered as its first participant in July 2026, deploying an AI-powered glucose health program that integrated G7 and Stelo CGM data with contextual nutrition, sleep, and activity signals. Edwards Lifesciences’ May 2025 HePI algorithm clearance and June 2026 Respiration Rate algorithm clearance showed how vendors expanded software revenue by adding AI-enabled parameter detection to existing connected hardware.

Interoperability and Electronic Health Record Integration Requirements

EHR integration advanced from a procurement preference to a contractual mandate for hospital-grade connected device software, as ONC’s FHIR interoperability rules required certified EHR technology to support standardized API interfaces across US non-federal acute care hospitals. Germany’s hospital sector followed a similar path, with SAP and Fresenius announcing a January 2026 collaboration to build a sovereign European health ecosystem using HL7 FHIR interfaces and KHZG digitalization program funding. FHIR adoption weakened proprietary data moats, increasing margin pressure on vendors without cross-platform analytics differentiation. ISO/IEC 80001-1 remained the leading global compliance framework, while EU MDR Article 83 added post-market software surveillance obligations for European market access.

AI-Enabled Predictive Monitoring and Clinical Workflow Automation

AI shifted from single-algorithm features to unified inference platforms embedded in connected monitoring hardware, creating continuous clinical intelligence capabilities that required sustained software investment. Masimo received FDA 510(k) clearance in June 2026 for AI-enabled OIRD detection on its Radius VSM wearable continuous patient monitor, combining SET pulse oximetry with advanced pattern recognition for escalating clinical alarms. Medtronic unveiled Touch Surgery Aide in July 2026, an AI-native surgical compute platform built on NVIDIA Holoscan and TensorRT for real-time OR insights in the Hugo robotic surgery system. The FDA’s January 2026 CDS guidance clarified regulatory pathways for continuous physiologic data streams, while the EU AI Act classified related AI-enabled medical device software as high risk.

Growth of Home-Based and Decentralized Care

Home-based care became the fastest-growing deployment environment for connected device software, supported by CMS reimbursement incentives, post-acute discharge pressure, and proven clinical equivalence across chronic indications. ResMed received FDA clearance in December 2025 for Smart Comfort, an AI-enabled digital medical device trained on more than 100 million de-identified nights of sleep data to recommend personalized CPAP comfort settings for home AirSense 11 users. ResMed’s AirConnect Dx launch for NHS sleep services in May 2026 reduced OSA referral-to-diagnosis time by 90–97%, from 3–12 months to 8–21 days, while tripling diagnostic capacity using existing staff. South Korea’s DMPA, effective January 2025, and Japan’s DASH for SaMD 2 program enabled faster APAC market entry for connected home monitoring software.

Fragmented Legacy Protocols and Proprietary Device Architectures

The installed device base across most large health systems includes HL7 v2, DICOM, proprietary serial protocols, and newer FHIR-enabled APIs. This architectural disparity limits the ability of vendor-neutral middleware to resolve integration challenges. Germany's DigitalRadar assessment scored hospitals on connected device integration as a discrete digitalization metric, and published interim data indicated that a material share of surveyed facilities still relied on manual data transfer between bedside devices and clinical information systems. China's NMPA released YY/T 1406-2026 in March 2026, revising software risk management requirements and requiring manufacturers with legacy validation frameworks to conduct fresh assessments before maintaining connected product market authorizations.

High Integration, Validation, and Lifecycle-Maintenance Costs

Software validation under IEC 62304 remains a sustained obligation, as connected device software requires regression testing with every hardware update, OS patch, and clinical workflow revision rather than a one-time approval event. The FDA's February 2026 cybersecurity guidance introduced mandatory SBOM documentation for all cyber devices under Section 524B, adding dependency-tracking obligations that small manufacturers without dedicated software quality infrastructure struggle to absorb. Compliance requirements under IEC 62304 and ISO 14971 apply globally, while EU MDR Article 61 adds a distinct post-market clinical evidence layer for European market access.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Component: Cloud Platforms Lead While Hybrid Systems Gain Ground

Cloud-based software held 48.22% of the connected medical device software market in 2025. It supported multi-site deployment, centralized alarm normalization, and rolling software updates, aligning with post-market maintenance and security management needs. Persistent connectivity also supported continuous clinical data review and periodic reporting obligations in Europe. On-premises software remained relevant where data residency rules limited cross-border health-data transfers, while large health systems in Asia-Pacific favored local deployment under national privacy and data-control rules.

Hybrid software is forecast to grow at a CAGR of 17.86% from 2026 to 2031, the fastest rate among component types. It enables time-sensitive processing at the bedside or local edge while storing longitudinal information in the cloud for population-level analysis. Hospital procurement teams increasingly specify hybrid-capable platforms in requests for proposals. The connected medical device software market size for hybrid solutions is supported by the need for both rapid response and enterprise-wide data access.

By Connectivity: Wired Networks Remain Central While Wireless Monitoring Expands

Wired connectivity held 57.68% of the connected medical device software market in 2025. Intensive care units and operating rooms continued to depend on hardwired networks for continuous critical monitoring. These settings required dependable connections and limited unmanaged radio-frequency interference. The connected medical device software market continued to rely on wired networks where uninterrupted high-acuity monitoring was required.

Wireless connectivity is forecast to grow at a CAGR of 19.67% from 2026 to 2031. Wi-Fi 6E and private 5G deployments address latency and interference concerns that previously restricted wireless monitoring to lower-acuity uses. Hospitals are adopting hybrid connectivity models that retain wired backup paths for critical alerts. The connected medical device software market size for wireless connectivity grows as hospitals extend monitoring beyond fixed bedside locations.Patient monitoring devices held 36.78% of the connected medical device software market in 2025. Their position reflected widespread use in intensive care, telemetry, and general ward environments. Medtronic and GE HealthCare expanded their alliance in March 2026 to integrate Nellcor pulse oximetry, Microstream capnography, INVOS regional oximetry, and BIS brain monitoring with GE HealthCare monitoring platforms. The collaboration reduced interface complexity for health systems operating devices from both companies.

Wearable and home medical devices are forecast to grow at a CAGR of 18.35% from 2026 to 2031. Their growth follows broader clinical acceptance of ambulatory monitoring for arrhythmia, glucose management, and sleep-disordered breathing. The ZEUS Platform received FDA 510(k) clearance in May 2026 as AI- and machine-learning-enabled software that analyzes continuous ECG recordings from Zio monitors and generates arrhythmia reports with 99% physician agreement. The connected medical device software market size for wearable and home devices benefits from these expanding clinical applications.

By Device Type: Patient Monitoring Leads While Wearables Extend Care Beyond Hospitals

Patient monitoring devices held 36.78% of the connected medical device software market in 2025. Their position reflected widespread use in intensive care, telemetry, and general ward environments. Medtronic and GE HealthCare expanded their alliance in March 2026 to integrate Nellcor pulse oximetry, Microstream capnography, INVOS regional oximetry, and BIS brain monitoring with GE HealthCare monitoring platforms. The collaboration reduced interface complexity for health systems operating devices from both companies.

Wearable and home medical devices are forecast to grow at a CAGR of 18.35% from 2026 to 2031. Their growth follows broader clinical acceptance of ambulatory monitoring for arrhythmia, glucose management, and sleep-disordered breathing. The ZEUS Platform received FDA 510(k) clearance in May 2026 as AI- and machine-learning-enabled software that analyzes continuous ECG recordings from Zio monitors and generates arrhythmia reports with 99% physician agreement. The connected medical device software market size for wearable and home devices benefits from these expanding clinical applications.

By Application: Continuous Monitoring Leads While Tele-ICU and Tele-Stroke Grow Fastest

Continuous patient monitoring held 45.37% of the connected medical device software market in 2025. Its scale came from established bedside monitoring across acute care environments, with rising adoption in step-down units and general wards. Edwards Lifesciences added AI-enabled parameter detection to its HemoSphere platform through the HePI and Respiration Rate algorithms. This strategy expanded software capability without requiring the replacement of installed hardware.

Tele-ICU and Tele-Stroke are forecast to grow at a CAGR of 19.45% from 2026 to 2031. Non-metropolitan hospitals need specialist support when intensivists and neurologists are not available on site. Improved real-time biosignal transmission allows remote specialists to review connected patient data and guide local teams. The connected medical device software market size for Tele-ICU and Tele-Stroke grows with the need to extend specialist oversight across facilities.

By End User: Hospitals Anchor Demand While Home Healthcare Providers Grow Faster

Hospitals and health systems held 66.45% of the connected medical device software market in 2025. They aggregated large device fleets and set interoperability and cybersecurity requirements across multiple clinical departments. Stryker's March 2026 SmartHospital Platform combined ambient sensing, voice-enabled communication, and alarm filtering for this environment. The connected medical device software market remained centered on hospitals because they were the main buyers of multi-brand orchestration platforms.

Home healthcare providers are forecast to grow at a CAGR of 17.45% from 2026 to 2031. Post-acute care needs and chronic disease management require monitoring that continues after hospital discharge. Skilled nursing and long-term care facilities present an additional opportunity because they manage patients with significant cardiopulmonary needs. The connected medical device software market size for home healthcare providers rises as care delivery moves beyond acute hospital walls.

Geography Analysis

North America held 39.76% of the connected medical device software market share in 2025. The region benefited from established remote monitoring reimbursement, high hospital device density, and active FDA oversight of digital health. The TEMPO pilot supported real-world evidence collection for software-enabled connected devices. U.S. hospitals also had a growing base of FHIR-based data exchange and standardized interfaces. Europe held the second-largest regional position, with Germany influencing procurement through EU MDR requirements, hospital digitalization funding, and its digital health environment.

Asia-Pacific is forecast to grow at a CAGR of 18.56% from 2026 to 2031, making it the fastest-growing regional market. Major regional markets are advancing regulatory modernization alongside healthcare infrastructure investment. Japan's DASH for SaMD 2 program supports faster review pathways for eligible connected monitoring software. South Korea's Digital Medical Products Act is increasing the relevance of digital health support devices for hospital buyers. China's revised YY/T 1406-2026 software requirements create demand for updated validation documentation, while India's private hospital groups and Australia's hospital-at-home programs are expanding adoption.

The Middle East and Africa and South America remain earlier-stage regions in the connected medical device software market. Adoption is concentrated among private healthcare groups and major public hospital projects. In GCC countries, new hospital construction offers a simpler integration environment than legacy upgrades in North America and Europe. Saudi Arabia's Vision 2030 programs and UAE digital health mandates support connected monitoring deployments, while Brazil's digital health activity and South Africa's health system changes indicate longer-term public-sector demand.